FI20031455A0 - Sulfonyyliamino-peptidomimeettejä, jotka ovat aktiivisia somatostatiinireseptorialatyyppien 4 (SSTR4) ja 1 (SSTR1) suhteen - Google Patents

Sulfonyyliamino-peptidomimeettejä, jotka ovat aktiivisia somatostatiinireseptorialatyyppien 4 (SSTR4) ja 1 (SSTR1) suhteen

Info

Publication number
FI20031455A0
FI20031455A0 FI20031455A FI20031455A FI20031455A0 FI 20031455 A0 FI20031455 A0 FI 20031455A0 FI 20031455 A FI20031455 A FI 20031455A FI 20031455 A FI20031455 A FI 20031455A FI 20031455 A0 FI20031455 A0 FI 20031455A0
Authority
FI
Finland
Prior art keywords
sstr4
sstr1
somatostatin receptor
peptidomimetics
sulfonylamino
Prior art date
Application number
FI20031455A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Inventor
Jussi Tomperi
Mia Engstroem
Siegfried Wurster
Original Assignee
Juvantia Pharma Ltd Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Juvantia Pharma Ltd Oy filed Critical Juvantia Pharma Ltd Oy
Priority to FI20031455A priority Critical patent/FI20031455A0/fi
Publication of FI20031455A0 publication Critical patent/FI20031455A0/fi
Priority to US10/574,905 priority patent/US20070129313A1/en
Priority to PCT/FI2004/000583 priority patent/WO2005033124A1/en
Priority to EP04767097A priority patent/EP1678196B1/en
Priority to DE602004015822T priority patent/DE602004015822D1/de
Priority to AT04767097T priority patent/ATE404580T1/de
Priority to JP2006530316A priority patent/JP2007507472A/ja

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • C07K5/06095—Arg-amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI20031455A 2003-10-06 2003-10-06 Sulfonyyliamino-peptidomimeettejä, jotka ovat aktiivisia somatostatiinireseptorialatyyppien 4 (SSTR4) ja 1 (SSTR1) suhteen FI20031455A0 (fi)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FI20031455A FI20031455A0 (fi) 2003-10-06 2003-10-06 Sulfonyyliamino-peptidomimeettejä, jotka ovat aktiivisia somatostatiinireseptorialatyyppien 4 (SSTR4) ja 1 (SSTR1) suhteen
US10/574,905 US20070129313A1 (en) 2003-10-06 2004-10-05 Sulfonylamino-peptidomimetics active on the somatostatin receptor subtypes 4 (sstr4) and 1 (sstr1)
PCT/FI2004/000583 WO2005033124A1 (en) 2003-10-06 2004-10-05 Sulfonylamino-peptidomimetics active on the somatostatin receptor subtypes 4 (sstr4) and 1 (sstr1)
EP04767097A EP1678196B1 (en) 2003-10-06 2004-10-05 Sulfonylamino-peptidomimetics active on the somatostatin receptor subtypes 4 (sstr4) and 1 (sstr1)
DE602004015822T DE602004015822D1 (de) 2003-10-06 2004-10-05 Sulfonylamino-peptidomimetika, die auf die somatostatinrezeptor-subtypen 4 (sstr4) und 1 (sstr1) wirken
AT04767097T ATE404580T1 (de) 2003-10-06 2004-10-05 Sulfonylamino-peptidomimetika, die auf die somatostatinrezeptor-subtypen 4 (sstr4) und 1 (sstr1) wirken
JP2006530316A JP2007507472A (ja) 2003-10-06 2004-10-05 ソマトスタチン受容体サブタイプ４（ｓｓｔｒ４）及び１（ｓｓｔｒ１）に作用するスルホニルアミノ−ペプチド模倣薬

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20031455A FI20031455A0 (fi) 2003-10-06 2003-10-06 Sulfonyyliamino-peptidomimeettejä, jotka ovat aktiivisia somatostatiinireseptorialatyyppien 4 (SSTR4) ja 1 (SSTR1) suhteen

Publications (1)

Publication Number Publication Date
FI20031455A0 true FI20031455A0 (fi) 2003-10-06

Family

ID=29225904

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20031455A FI20031455A0 (fi) 2003-10-06 2003-10-06 Sulfonyyliamino-peptidomimeettejä, jotka ovat aktiivisia somatostatiinireseptorialatyyppien 4 (SSTR4) ja 1 (SSTR1) suhteen

Country Status (6)

Country Link
US (1) US20070129313A1 (cg-RX-API-DMAC7.html)
EP (1) EP1678196B1 (cg-RX-API-DMAC7.html)
JP (1) JP2007507472A (cg-RX-API-DMAC7.html)
AT (1) ATE404580T1 (cg-RX-API-DMAC7.html)
FI (1) FI20031455A0 (cg-RX-API-DMAC7.html)
WO (1) WO2005033124A1 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20031454A0 (fi) * 2003-10-06 2003-10-06 Juvantia Pharma Ltd Oy Selektiivisiä somatostatiinireseptori 1 ja/tai 4 -agonisteja ja -antagonisteja
US20100004339A1 (en) * 2003-10-06 2010-01-07 Oy Juvantia Pharma Ltd. Somatostatin Receptor 1 and/or 4 Selective Agonists and Antagonists
WO2005082845A1 (en) * 2004-02-27 2005-09-09 Oy Juvantia Pharma Ltd Novel therapies with somatostatin receptor agonists
WO2005082844A1 (en) * 2004-02-27 2005-09-09 Oy Juvantia Pharma Ltd Treatment of diseases by using a somatostatin receptor agonist
US20100048549A1 (en) * 2005-05-18 2010-02-25 Siegfried Wurster Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4
US11136312B2 (en) 2017-05-12 2021-10-05 Board of Trustees of the Southern Illinois University 3,4,5-trisubstituted-1,2,4-triazoles and 3,4,5-trisubstituted-3-thio-1,2,4-triazoles and uses thereof
US11912687B2 (en) 2017-05-12 2024-02-27 Board of Trustees of the Southern Illinois University 3,4,5-trisubstituted-1,2,4-triazoles and 3,4,5-trisubstituted-3-thio-1,2,4-triazoles and uses thereof
JP7099717B2 (ja) * 2019-09-30 2022-07-12 株式会社理研バイオ ソマトスタチン受容体
AR121683A1 (es) * 2020-03-31 2022-06-29 Takeda Pharmaceuticals Co Derivados de n-heteroarilalquil-2-(heterociclil y heterociclilmetil)acetamida como agonistas de sstr4
WO2025247982A1 (en) 2024-05-29 2025-12-04 Grünenthal GmbH Piperazines which act as sstr4 modulators

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1535264A (zh) * 2001-05-15 2004-10-06 ������ҩ��ʽ���� 精氨酸衍生物
AU2002330090A1 (en) * 2001-09-24 2003-04-07 Synaptic Pharmaceutical Corporation Molecules specific for npff receptors and uses thereof
WO2003026657A1 (en) * 2001-09-24 2003-04-03 Synaptic Pharmaceutical Corporation Compounds for the treatment of pain
JP2004155695A (ja) * 2002-11-06 2004-06-03 Taisho Pharmaceut Co Ltd Ｍｃ４受容体に対するリガンド
FI20031454A0 (fi) * 2003-10-06 2003-10-06 Juvantia Pharma Ltd Oy Selektiivisiä somatostatiinireseptori 1 ja/tai 4 -agonisteja ja -antagonisteja

Also Published As

Publication number Publication date
WO2005033124A1 (en) 2005-04-14
JP2007507472A (ja) 2007-03-29
EP1678196B1 (en) 2008-08-13
US20070129313A1 (en) 2007-06-07
ATE404580T1 (de) 2008-08-15
EP1678196A1 (en) 2006-07-12

Similar Documents

Publication Publication Date Title
DK1337518T3 (da) Piperazinylpyrazinforbindelser som antagonister for serotonin-5-HT2-receptoren
NO20034289L (no) N-(2-aryletyl)benzylaminer som antagonister av 5-HT6- reseptoren
BR0306150A (pt) Composto, uso de um composto, e, composição farmacêutica
TW200637550A (en) Thiazole-4-carboxamide derivatives as mGluR5 antagonists
DE602004012858D1 (de) 2-aminobenzothiazole als cb1 rezeptor inverse agonisten
ATE396993T1 (de) Tetrahydropyranyl-cyclopentyl- tetrahydropyridopyridin-modulatoren der chemokin- rezeptor-aktivität
ZA201102735B (en) Antagonists of the vanilloid receptor subtype 1(vr1) and uses thereof
MXPA06012595A (es) Analogos de amino-tetrazoles y metodos de uso.
NO20032252L (no) Piperazinylpyrazinforbindelser som agonist eller antagonist av serotonin 5HT-2-reseptor
WO2002010140A3 (en) Imidazolyl derivatives
MX2009010552A (es) Antagonistas de receptor de opioide periferico y usos de los mismos.
FI20031455A0 (fi) Sulfonyyliamino-peptidomimeettejä, jotka ovat aktiivisia somatostatiinireseptorialatyyppien 4 (SSTR4) ja 1 (SSTR1) suhteen
ATE374190T1 (de) Tetrahydrochinazolinderivate als cfr-antagonisten
SE0103710D0 (sv) Compounds
TNSN07015A1 (en) Kynurenic acid amide derivatives as nr2b receptor antagonists
TW200744593A (en) Thrombin receptor antagonists as prophylaxis to complications from cardiopulmonary surgery
MXPA05013149A (es) Derivados de imidazol como antagonistas del receptor de glutamato.
TW200621752A (en) Pyrimidinylpyrazoles and methods of making and using the same
DK1644389T3 (da) Pyrinidinforbindelser med phosphonatgrupper som antivirale nukleotidanaloger
MXPA05005198A (es) Derivados de imidazoquinolina, como ligandos del receptor a3 de adenosina.
FI20031454A0 (fi) Selektiivisiä somatostatiinireseptori 1 ja/tai 4 -agonisteja ja -antagonisteja
NO20084698L (no) Metode for fremstilling av indazolyl-ureaer som inhiberer vanilloidreseptor subtype 1(VR1)
DE602004016328D1 (de) 2-imidazo-benzothiazole als adenosin-rezeptor liganden
BRPI0516602A (pt) composto, e, composição farmacêutica
DE60319989D1 (de) Diazabicylononan - und decanderivate und ihre verwendung als opioid-rezeptorligande

Legal Events

Date Code Title Description
FD Application lapsed